Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Pfizer Merger to Shut Down Six R&D Sites, Resulting in 2,000 Layoffs, an Industrial Info News Alert


Print article Print article
Refer this article Refer to a friend
© Marketwire 2009
2009-11-11 11:28:01 -

SAN DIEGO, CA -- (Marketwire) -- 11/11/09 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Early Monday morning, the buzz at the International Society of Pharmaceutical Engineers (ISPE) conference in San Diego, California, was that Pfizer Incorporated : (NYSE:PFE) (New York, New York) was planning to sell its massive St. Louis/Chesterfield, Missouri, research : site to Monsanto Company : (NYSE:MON) (St. Louis). By day's end, the truth had proven to be more dramatic than the rumors: To achieve a 35% reduction in global square footage, the company is going to close six research and development sites across the United States and lay off an estimated 2,000 people.



For details, view the entire article by subscribing to Industrial Info's Premium Industry News at www.industrialinfo.com/showNews.jsp?newsitemID=152347 : , or browse other breaking industrial news stories at www.industrialinfo.com : .



Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy related markets. For more than 26 years, Industrial Info has provided plant and project opportunity databases, market forecasts, high resolution maps, and daily industry news. For more information send inquiries to pharmabiogroup@industrialinfo.com : mailto:pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com : .
Add to Digg : Bookmark with del.icio.us : Add to Newsvine :



Contact:
Joe Govreau
713-783-5147




Disclaimer: (c) 2009 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com